Selling And Administration Expenses Changement Date
Amarin USD 45.46M 5.5M 2023-09
Ardelyx USD 32.66M 5.48M 2023-09
Baxter International USD 832M 47M 2023-12
Bayer EUR 3.6B 81M 2023-09
BioCryst Pharmaceuticals USD 50.65M 349K 2023-09
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Esperion Therapeutics USD 33.24M 719K 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Insmed USD 89.53M 1.1M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
J&J USD 5.81B 410M 2023-12
Lexicon Pharmaceuticals USD 32.23M 2.22M 2023-09
Moderna USD 470M 28M 2023-12
Omeros USD 16.42M 5.16M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
PTC Therapeutics USD 76.29M 4.6M 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Teva Pharmaceutical Industries USD 844M 66M 2023-09
United Therapeutics USD 128.6M 1000K 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



United Therapeutics Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.